Stay updated on LN-145 & Durvalumab Combo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.3%
    Check dated 2025-09-07T13:36:31.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new drug information for Lifileucel and details on various receptors. However, it has also removed specific location details and previous drug information for Durvalumab.
    Difference
    4%
    Check dated 2025-08-31T11:34:54.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-17T01:32:42.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.10 to version 2.16.11.
    Difference
    0.1%
    Check dated 2025-08-09T20:08:45.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a service alert regarding planned maintenance has been removed.
    Difference
    1%
    Check dated 2025-08-02T15:26:13.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.8, and the HHS Vulnerability Disclosure has been added.
    Difference
    0.3%
    Check dated 2025-07-26T14:24:22.000Z thumbnail image

Stay in the know with updates to LN-145 & Durvalumab Combo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LN-145 & Durvalumab Combo in NSCLC Clinical Trial page.